Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis

Abstract Background This pairwise meta-analysis determines the difference in bleeding risks associated with the use of novel oral anticoagulants (NOACs) and aspirin. Methods PubMed, the Cochrane Library database, clinicaltrial.gov , and related studies were searched for randomized control trials (RC...

Full description

Bibliographic Details
Main Authors: Xiehui Chen, Weichao Huang, Aimei Sun, Lili Wang, Fanrui Mo, Wenqin Guo
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Thrombosis Journal
Subjects:
Online Access:https://doi.org/10.1186/s12959-021-00322-6